BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
34.82
+0.18 (0.52%)
Aug 11, 2026, 4:00 PM EDT - Market closed
BioLife Solutions Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 28.07 | 96.21 | 74.65 | 68.02 | 76.24 | 119.16 |
Revenue Growth | 31.21% | 28.89% | 9.75% | -10.79% | -36.02% | 147.79% |
Gross Profit Gross Profit Growth | 17.92 | 62.12 | 50.1 | 41.32 | 46.91 | 37.05 |
Operating Income Operating Income Growth | -44.78 | -16.6 | -4.48 | -17.21 | -5.92 | -35.16 |
Net Income Net Income Growth | 57.98 | -4.6 | -20.18 | -68 | -139.81 | -48.17 |
Earnings Per Share EPS Growth | 1.16 | -0.10 | -0.44 | -0.42 | 0.01 | -0.23 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 83.53 | 76.97 | 55.99 | 55.09 | 62.52 | 101.28 |
Europe, Middle East, Africa (EMEA) Europe, Middle East, Africa (EMEA) Growth | 16.3 | 13.47 | 14.18 | 8.16 | 9.15 | 13.11 |
Other Other Growth | 6.86 | 5.77 | 4.48 | 4.76 | 4.57 | 4.77 |
Total Total Growth | 106.69 | 96.21 | 74.65 | 68.02 | 76.24 | 119.16 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 82.42 | 88.93 | 100.74 | 44.18 | 62.7 | 69.86 |
Total Debt Total Debt Growth | 15.74 | 17.9 | 30.04 | 33.83 | 43.71 | 26.88 |
Net Cash (Debt) Net Cash Growth | 66.68 | 71.03 | 70.69 | 10.36 | 18.99 | 42.98 |
Net Cash Growth | 15.06% | 0.48% | 582.55% | -45.46% | -55.82% | -45.77% |
Net Cash Per Share Net Cash Per Share Growth | 1.36 | 1.46 | 1.53 | 0.24 | 0.44 | 1.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6.1 | 20.12 | 8.43 | -12.5 | -8.49 | -4.59 |
Capital Expenditures CapEx Growth | -8.77 | -9.48 | -3.23 | -6.38 | -10.39 | -8.39 |
Free Cash Flow Free Cash Flow Growth | -2.67 | 10.64 | 5.2 | -18.88 | -18.87 | -12.98 |
Free Cash Flow Growth | - | 104.40% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.85% | 64.56% | 67.11% | 60.75% | 61.53% | 31.09% |
Operating Margin | -159.54% | -17.26% | -6.00% | -25.30% | -7.77% | -29.51% |
Pretax Margin | -144.39% | -18.18% | -9.77% | -13.83% | -5.61% | -23.55% |
Profit Margin | 179.73% | -12.61% | -11.77% | -17.87% | 0.51% | -40.43% |
FCF Margin | -9.50% | 11.06% | 6.97% | -27.76% | -24.75% | -10.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.93 | - | - | - | 1820.00 | - |
Forward PE | 121.45 | 299.08 | 223.59 | 223.59 | 223.59 | 223.59 |
P/FCF Ratio | 223.10 | 109.57 | 233.99 | - | - | - |
PS Ratio | 15.96 | 12.11 | 16.31 | 10.79 | 10.23 | 13.08 |